Related references
Note: Only part of the references are listed.Adjuvant Chemotherapy After Resection of Colorectal Liver Metastases in Patients at High Risk of Hepatic Recurrence A Comparative Study Between Hepatic Arterial Infusion of Oxaliplatin and Modern Systemic Chemotherapy
Diane Goere et al.
ANNALS OF SURGERY (2013)
Margin Status Remains an Important Determinant of Survival After Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy
Andreas Andreou et al.
ANNALS OF SURGERY (2013)
Perioperative chemotherapy for resectable colorectal liver metastases: Where now?
R. P. Jones et al.
EJSO (2013)
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
Bernard Nordlinger et al.
LANCET ONCOLOGY (2013)
Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983)
Halfdan Sorbye et al.
ANNALS OF SURGERY (2012)
A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery
Toru Beppu et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2012)
Comparison of Adjuvant Systemic Chemotherapy With or Without Hepatic Arterial Infusional Chemotherapy After Hepatic Resection for Metastatic Colorectal Cancer
Michael G. House et al.
ANNALS OF SURGERY (2011)
Is Perioperative Chemotherapy Useful for Solitary, Metachronous, Colorectal Liver Metastases?
Rene Adam et al.
ANNALS OF SURGERY (2010)
A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment
Nikol Snoeren et al.
BMC CANCER (2010)
A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer
M. Ychou et al.
ANNALS OF ONCOLOGY (2009)
Validation of Prognostic Scoring Systems for Patients Undergoing Resection of Colorectal Cancer Liver Metastases
Christoph Reissfelder et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
Thierry Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Resected Colorectal Liver Metastases: Does the Survival Differ According to Postoperative Chemotherapy Regimen?
Sun Young Kim et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer - A multifactorial model of 929 patients
Myrddin Rees et al.
ANNALS OF SURGERY (2008)
A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer
Michael W. Kattan et al.
ANNALS OF SURGERY (2008)
Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials
Emmanuel Mitry et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
Bernard Nordlinger et al.
LANCET (2008)
Hepatic resection for colorectal metastases - Value for risk scoring systems?
Shaheen Zakaria et al.
ANNALS OF SURGERY (2007)
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07
J. Philip Kuebler et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Survival after hepatic resection in metastatic colorectal cancer - A population-based study
Linda C. Cummings et al.
CANCER (2007)
Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial
Guillaume Portier et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Solitary colorectal liver metastasis - Resection determines outcome
TA Aloia et al.
ARCHIVES OF SURGERY (2006)
Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies
PC Simmonds et al.
BRITISH JOURNAL OF CANCER (2006)
A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer
J Leporrier et al.
BRITISH JOURNAL OF SURGERY (2006)
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment
A Trotti et al.
SEMINARS IN RADIATION ONCOLOGY (2003)
Radiologic placement of side-hole catheter with tip fixation for hepatic arterial infusion chemotherapy
T Tanaka et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2003)
Trends in long-term survival following liver resection for hepatic colorectal metastases
MA Choti et al.
ANNALS OF SURGERY (2002)
Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - An intergroup study
MM Kemeny et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
